Adalimumab works like a CHARM in Crohn's disease.
In: PharmacoEconomics & Outcomes News, 2009-07-11, Heft 582, S. 9-10
serialPeriodical
Zugriff:
The article talks about three analyses presented at the 2009 Digestive Diseases Week conference which showed that over a 3-year follow-up period, quality of life (QOL) improvements achieved with adalimumab during the Crohn's Trial of the Fully Human Antibody Adalimumab for Remission Maintenance (CHARM) were sustained. 58.8% and 56.4% of patients achieved an Inflammatory Bowel Disease Questionnaire (IBDQ) score of at least 170 at 2 and 3 years followup, respectively.
Titel: |
Adalimumab works like a CHARM in Crohn's disease.
|
---|---|
Autor/in / Beteiligte Person: | Wright, Tracey |
Zeitschrift: | PharmacoEconomics & Outcomes News, 2009-07-11, Heft 582, S. 9-10 |
Veröffentlichung: | 2009 |
Medientyp: | serialPeriodical |
ISSN: | 1173-5503 (print) |
DOI: | 10.2165/00151234-200905820-00020 |
Schlagwort: |
|
Sonstiges: |
|